BlackRock Institutional Trust’s Larimar Therapeutics LRMR Stock Holding History

BlackRock Institutional Trust’s Portfolio LRMR Stock Details LRMR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$1.59M	Sell	41,769 -157	-0.4%	-$6.37K	﹤0.01%	3138
2016 Q3	$1.67M	Hold	41,926	–	–	﹤0.01%	3122
2016 Q2	$3.01M	Buy	41,926 +7,996	+24%	+$632K	﹤0.01%	2885
2016 Q1	$2.72M	Sell	33,930 -212	-0.6%	-$16.7K	﹤0.01%	2914
2015 Q4	$2.58M	Buy	34,142 +371	+1%	+$59.6K	﹤0.01%	3014
2015 Q3	$12.9M	Buy	33,771 +15,114	+81%	+$6.81M	﹤0.01%	2120
2015 Q2	$7.75M	Buy	18,657 +8,177	+78%	+$3.42M	﹤0.01%	2549
2015 Q1	$4.98M	Buy	10,480 +5,439	+108%	+$2.58M	﹤0.01%	2764
2014 Q4	$1.87M	Buy	5,041 +437	+9%	+$113K	﹤0.01%	3137
2014 Q3	$1.09M	Buy	+4,604	New	+$1.04M	﹤0.01%	3296

Other funds holding LRMR

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FCMI

Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return

6CM

683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return

FCMI

Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

BlackRock Institutional Trust's LRMR Position: Q4 2016 in Review

BlackRock Institutional Trust reduced its Larimar Therapeutics (LRMR) stake by 0.37% in Q4 2016, selling an estimated $6.37K and leaving 41,769 shares worth $1.59M. The position accounts for ﹤0.01% of the portfolio, ranked #3138.

BlackRock Institutional Trust first reported a position in LRMR in Q3 2014 and has held it in 10 quarters since. The position peaked at $12.9M in Q3 2015. 81 funds tracked by Wall St. Rank hold LRMR as of Q4 2016.

BlackRock Institutional Trust held 41,769 shares of Larimar Therapeutics worth $1.59M as of Q4 2016.
BlackRock Institutional Trust sold 157 Larimar Therapeutics shares in Q4 2016, an estimated $6.37K.
Larimar Therapeutics made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #3138 holding.
BlackRock Institutional Trust first reported a position in Larimar Therapeutics in Q3 2014 and has held it in 10 quarters since.
BlackRock Institutional Trust's Larimar Therapeutics position peaked at $12.9M in Q3 2015.
81 funds tracked by Wall St. Rank held Larimar Therapeutics as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.